Ann Phys Rehabil Med

Autor: Patrick Dehail, C. Delleci, H. Petit, Mélanie Cogné, Mathieu De Sèze, Alexandre Creuzé
Přispěvatelé: Bordeaux population health (BPH), Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Bordeaux [Bordeaux], Handicap Activité Cognition Santé [Bordeaux] (HACS), Université de Bordeaux (UB)-Institut National de Recherche en Informatique et en Automatique (Inria)-CHU Bordeaux [Bordeaux]-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Pontchaillou [Rennes]
Rok vydání: 2018
Předmět:
Zdroj: Annals of Physical and Rehabilitation Medicine
Annals of Physical and Rehabilitation Medicine, Elsevier Masson, 2019, 62 (5), pp.336-341. ⟨10.1016/j.rehab.2018.12.003⟩
Annals of Physical and Rehabilitation Medicine, 2019, 62 (5), pp.336-341. ⟨10.1016/j.rehab.2018.12.003⟩
ISSN: 1877-0665
1877-0657
DOI: 10.1016/j.rehab.2018.12.003⟩
Popis: International audience; BACKGROUND: Epicondylar tendinopathy ("tennis elbow") is a serious issue in manual labourers. Symptoms can persist over months or even more than 1 year, even when treated with trinitrine patches, acupuncture, sclerosis of neovessels, shock-wave therapy, autologous blood injections, platelet-rich plasma or hyaluronic acid. Botulinum toxin (BoNT-A) injections showed promising short-term results, but the long-term beneficial effects are not yet known. OBJECTIVE: We aimed to assess the long-term effect, side effects and recurrence rate after BoNT-A injections on chronic lateral epicondylar tendinopathy during 1 year. METHODS: This open study followed a 3-month randomized controlled trial. We included 50 patients followed at day 0 (V0), 90 (V1), 180-270 (V2) and 365 (V3). The main judgment criterion was the number of BoNT-A injections required to achieve pain relief with no further request for treatment by the patient. RESULTS: After one BoNT-A injection, 22/50 (44%) patients did not ask for further treatment during follow-up because of complete pain relief, and 20/50 (40%) asked for a second BoNT-A injection. For 20 patients with a second injection, 18 (90%) did not ask for further treatment during follow-up. Only 1 patient had a recurrence of pain after an initial pain relief of greater than 75%. Quality of life, and painful and maximal gripping force improved significantly at V1, V2 and V3 as compared with V0, and repercussions on daily and professional activities decreased significantly (P
Databáze: OpenAIRE
Externí odkaz: